Skip to main content
Publications
Perugini M, Johnson TJ, Beume TM, Dong OM , Guerino J, Hu H, Kerr K, Kindilien S, Nuijten M, Ofili TU, Taylor M, Wong A, Freijer K. Are we ready for a new approach to comparing coverage and reimbursement policies for medical nutrition in key markets: an ISPOR special interest group report . Value Health. 2022 May;25(5):677-84. doi: 10.1016/j.jval.2022.01.011
Boucher N, Van Voorhees E, Vashi A, Dong O , Morgan P, Smith JE, Adam S, Alishahi A, Mulholland MJ, Dietch JR, Whited JD, Boggan JC, Fulton JJ, Cameron CB, Gordon A, Goldstein KM, Ear B, Williams JW, Cantrell S, Dickerson SW, Gierisch JM. Tele-urgent care for low-acuity conditions: a systematic review . 2022.
Spelman T, Herring WL , Zhang Y, Tempest M, Pearson I , Freudensprung U, Acosta C, Dort T, Hyde R, Havrdova E, Horakova D, Trojano M, De Luca G, Lugaresi A, Izquierdo G, Grammond P, Duquette P, Alroughani R, Pucci E, Granella F, Lechner-Scott J, Sola P, Ferraro D, Grand’Maison F, Terzi M, Rozsa C, Boz C, Hupperts R, Van Pesch V, Oreja-Guevara C, van der Walt A, Jokubaitis VG, Kalincik T, Butzkueven H. Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in patients with inadequate response to disease-modifying therapies in relapsing-remitting multiple sclerosis in the United Kingdom . Pharmacoeconomics. 2022 Mar;40(3):323-39. doi: 10.1007/s40273-021-01106-6.
Law EH, Galve-Calvo E, Wockel A, Parikh R , Kurosky SK, Derrien Ansquer V , Frugier G , Davis KL , Esterberg E , Oikonomidou O. European treatment patterns and outcomes associated with first-line CDK4/6 inhibition and hormonal therapies assessed in a real-world non-interventional study (EUCHARIS) . Poster presented at the 2021 San Antonio Breast Cancer Symposium (SABCS); December 7, 2021. San Antonio, TX. [abstract] Cancer Res. 2022 Feb 15; 82(4_Suppl):OT2-19-04. doi: 10.1158/1538-7445.SABCS21-OT2-19-04
Sperber N, Dong O , Roberts M, Dexter P, Elsey A, Ginsburg G, Horowitz C, Johnson J, Levy K, Ong H, Peterson J, Pollin T, Rakhra-Burris TK, Ramos M, Skaar T, Orlando L. How does the eric typology apply to implementation of clinical decision support for genomic medicine?: specifying and reporting implementation strategies for desired outcomes among a genomic medicine implementation network . Presented at the 14th Annual Conference on the Science of Dissemination and Implementation in Health; December 15, 2021.
Carrico J, Mellott C, Talbird S , Abreu A, Merckx B, Vanderhaute J, Benchabane D, Dauby N, Ethgen O, Lepage P, Luyten J, Raes M, Simoens S, Van Ranst M, Bencina G, Nyaku MK. Economic evaluation of the pediatric immunization program in Belgium . Poster presented at the Virtual ISPOR Europe 2021; November 30, 2021. [abstract] Value Health. 2021 Dec; 24(12):S2.
Shah R, Girard N, Nagar SP , Griesinger F, Roeper J, Davis KL , Karimi P, Sawyer W, Yu N, Taylor A, Feliciano J. European and US real-world treatment patterns in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer: a retrospective medical record review . Drugs Real World Outcomes. 2021 Dec;8(4):537-45. doi: 10.1007/s40801-021-00261-8
Germing U, Goyal RK , Yucel A, Parikh RC , Jimenez M , Sluga-O'Callaghan M , Tang D, Hughes C, Diez-Campelo M. Real-world evidence on treatment utilization in lower-risk myelodysplastic syndromes: findings from a medical record review in the United States . Poster presented at the 63rd ASH Annual Meeting and Exposition; December 11, 2021. Atlanta, GA. [abstract] Blood. 2021 Nov 23; 138(Suppl 1):4666. doi: 10.1182/blood-2021-145576